Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions

Tanja Taivassalo, Julie L. Gardner, Robert W. Taylor, Andrew M. Schaefer, Jane Newman, Martin J. Barron, Ronald G. Haller, Douglass M. Turnbull

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

At present there are limited therapeutic interventions for patients with mitochondrial myopathies. Exercise training has been suggested as an approach to improve physical capacity and quality of life but it is uncertain whether it offers a safe and effective treatment for patients with heteroplasmic mitochondrial DNA (mtDNA) mutations. The objectives of this study were to assess the effects of exercise training and detraining in eight patients with single, large-scale mtDNA deletions to determine: (i) the efficacy and safety of endurance training (14 weeks) in this patient population; (ii) to determine the effect of more prolonged (total of 28 weeks) exercise training upon muscle and cardiovascular function and (iii) to evaluate the effect of discontinued training (14 weeks) upon muscle and cardiovascular function. Our results show that: (i) 14 weeks of exercise training significantly improved tolerance of submaximal exercise and peak capacity for work, oxygen utilization and skeletal muscle oxygen extraction with no change in the level of deleted mtDNA; (ii) continued training for an additional 14 weeks maintained these beneficial adaptations; (iii) the cessation of training (detraining) resulted in loss of physiological adaptation to baseline capacity with no overall change in mutation load. Patients' self assessment of quality of life as measured by the SF-36 questionnaire improved with training and declined with detraining. Whilst our findings of beneficial effects of training on physiological outcome and quality of life without increases in the percentage of deleted mtDNA are encouraging, we did not observe changes in mtDNA copy number. Therefore there remains a need for longer term studies to confirm that endurance exercise is a safe and effective treatment for patients with mitochondrial myopathies. The effects of detraining clearly implicate physical inactivity as an important mechanism in reducing exercise capacity and quality of life in patients with mitochondrial myopathy.

Original languageEnglish (US)
Pages (from-to)3391-3401
Number of pages11
JournalBrain
Volume129
Issue number12
DOIs
StatePublished - Dec 2006

Fingerprint

Mitochondrial Myopathies
Mitochondrial DNA
Exercise
Quality of Life
Oxygen
Physiological Adaptation
Muscles
Mutation
Exercise Tolerance
Skeletal Muscle
Therapeutics
Safety

Keywords

  • Deletions
  • Exercise training
  • Mitochondrial myopathy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Taivassalo, T., Gardner, J. L., Taylor, R. W., Schaefer, A. M., Newman, J., Barron, M. J., ... Turnbull, D. M. (2006). Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain, 129(12), 3391-3401. https://doi.org/10.1093/brain/awl282

Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. / Taivassalo, Tanja; Gardner, Julie L.; Taylor, Robert W.; Schaefer, Andrew M.; Newman, Jane; Barron, Martin J.; Haller, Ronald G.; Turnbull, Douglass M.

In: Brain, Vol. 129, No. 12, 12.2006, p. 3391-3401.

Research output: Contribution to journalArticle

Taivassalo, T, Gardner, JL, Taylor, RW, Schaefer, AM, Newman, J, Barron, MJ, Haller, RG & Turnbull, DM 2006, 'Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions', Brain, vol. 129, no. 12, pp. 3391-3401. https://doi.org/10.1093/brain/awl282
Taivassalo T, Gardner JL, Taylor RW, Schaefer AM, Newman J, Barron MJ et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain. 2006 Dec;129(12):3391-3401. https://doi.org/10.1093/brain/awl282
Taivassalo, Tanja ; Gardner, Julie L. ; Taylor, Robert W. ; Schaefer, Andrew M. ; Newman, Jane ; Barron, Martin J. ; Haller, Ronald G. ; Turnbull, Douglass M. / Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. In: Brain. 2006 ; Vol. 129, No. 12. pp. 3391-3401.
@article{7ce6eaa266d740ef8202f26897d7671f,
title = "Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions",
abstract = "At present there are limited therapeutic interventions for patients with mitochondrial myopathies. Exercise training has been suggested as an approach to improve physical capacity and quality of life but it is uncertain whether it offers a safe and effective treatment for patients with heteroplasmic mitochondrial DNA (mtDNA) mutations. The objectives of this study were to assess the effects of exercise training and detraining in eight patients with single, large-scale mtDNA deletions to determine: (i) the efficacy and safety of endurance training (14 weeks) in this patient population; (ii) to determine the effect of more prolonged (total of 28 weeks) exercise training upon muscle and cardiovascular function and (iii) to evaluate the effect of discontinued training (14 weeks) upon muscle and cardiovascular function. Our results show that: (i) 14 weeks of exercise training significantly improved tolerance of submaximal exercise and peak capacity for work, oxygen utilization and skeletal muscle oxygen extraction with no change in the level of deleted mtDNA; (ii) continued training for an additional 14 weeks maintained these beneficial adaptations; (iii) the cessation of training (detraining) resulted in loss of physiological adaptation to baseline capacity with no overall change in mutation load. Patients' self assessment of quality of life as measured by the SF-36 questionnaire improved with training and declined with detraining. Whilst our findings of beneficial effects of training on physiological outcome and quality of life without increases in the percentage of deleted mtDNA are encouraging, we did not observe changes in mtDNA copy number. Therefore there remains a need for longer term studies to confirm that endurance exercise is a safe and effective treatment for patients with mitochondrial myopathies. The effects of detraining clearly implicate physical inactivity as an important mechanism in reducing exercise capacity and quality of life in patients with mitochondrial myopathy.",
keywords = "Deletions, Exercise training, Mitochondrial myopathy",
author = "Tanja Taivassalo and Gardner, {Julie L.} and Taylor, {Robert W.} and Schaefer, {Andrew M.} and Jane Newman and Barron, {Martin J.} and Haller, {Ronald G.} and Turnbull, {Douglass M.}",
year = "2006",
month = "12",
doi = "10.1093/brain/awl282",
language = "English (US)",
volume = "129",
pages = "3391--3401",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions

AU - Taivassalo, Tanja

AU - Gardner, Julie L.

AU - Taylor, Robert W.

AU - Schaefer, Andrew M.

AU - Newman, Jane

AU - Barron, Martin J.

AU - Haller, Ronald G.

AU - Turnbull, Douglass M.

PY - 2006/12

Y1 - 2006/12

N2 - At present there are limited therapeutic interventions for patients with mitochondrial myopathies. Exercise training has been suggested as an approach to improve physical capacity and quality of life but it is uncertain whether it offers a safe and effective treatment for patients with heteroplasmic mitochondrial DNA (mtDNA) mutations. The objectives of this study were to assess the effects of exercise training and detraining in eight patients with single, large-scale mtDNA deletions to determine: (i) the efficacy and safety of endurance training (14 weeks) in this patient population; (ii) to determine the effect of more prolonged (total of 28 weeks) exercise training upon muscle and cardiovascular function and (iii) to evaluate the effect of discontinued training (14 weeks) upon muscle and cardiovascular function. Our results show that: (i) 14 weeks of exercise training significantly improved tolerance of submaximal exercise and peak capacity for work, oxygen utilization and skeletal muscle oxygen extraction with no change in the level of deleted mtDNA; (ii) continued training for an additional 14 weeks maintained these beneficial adaptations; (iii) the cessation of training (detraining) resulted in loss of physiological adaptation to baseline capacity with no overall change in mutation load. Patients' self assessment of quality of life as measured by the SF-36 questionnaire improved with training and declined with detraining. Whilst our findings of beneficial effects of training on physiological outcome and quality of life without increases in the percentage of deleted mtDNA are encouraging, we did not observe changes in mtDNA copy number. Therefore there remains a need for longer term studies to confirm that endurance exercise is a safe and effective treatment for patients with mitochondrial myopathies. The effects of detraining clearly implicate physical inactivity as an important mechanism in reducing exercise capacity and quality of life in patients with mitochondrial myopathy.

AB - At present there are limited therapeutic interventions for patients with mitochondrial myopathies. Exercise training has been suggested as an approach to improve physical capacity and quality of life but it is uncertain whether it offers a safe and effective treatment for patients with heteroplasmic mitochondrial DNA (mtDNA) mutations. The objectives of this study were to assess the effects of exercise training and detraining in eight patients with single, large-scale mtDNA deletions to determine: (i) the efficacy and safety of endurance training (14 weeks) in this patient population; (ii) to determine the effect of more prolonged (total of 28 weeks) exercise training upon muscle and cardiovascular function and (iii) to evaluate the effect of discontinued training (14 weeks) upon muscle and cardiovascular function. Our results show that: (i) 14 weeks of exercise training significantly improved tolerance of submaximal exercise and peak capacity for work, oxygen utilization and skeletal muscle oxygen extraction with no change in the level of deleted mtDNA; (ii) continued training for an additional 14 weeks maintained these beneficial adaptations; (iii) the cessation of training (detraining) resulted in loss of physiological adaptation to baseline capacity with no overall change in mutation load. Patients' self assessment of quality of life as measured by the SF-36 questionnaire improved with training and declined with detraining. Whilst our findings of beneficial effects of training on physiological outcome and quality of life without increases in the percentage of deleted mtDNA are encouraging, we did not observe changes in mtDNA copy number. Therefore there remains a need for longer term studies to confirm that endurance exercise is a safe and effective treatment for patients with mitochondrial myopathies. The effects of detraining clearly implicate physical inactivity as an important mechanism in reducing exercise capacity and quality of life in patients with mitochondrial myopathy.

KW - Deletions

KW - Exercise training

KW - Mitochondrial myopathy

UR - http://www.scopus.com/inward/record.url?scp=33845285545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845285545&partnerID=8YFLogxK

U2 - 10.1093/brain/awl282

DO - 10.1093/brain/awl282

M3 - Article

C2 - 17085458

AN - SCOPUS:33845285545

VL - 129

SP - 3391

EP - 3401

JO - Brain

JF - Brain

SN - 0006-8950

IS - 12

ER -